GH Guardant Health, Inc.
P/E
--
Forward P/E
--
Price/Sales
19.18
Beta
1.583
Div Yield
--
Market Cap
--
Company Analysis
Latest News
Guardant Health Appoints Former Dexcom CEO to Board and Names New Chief Accounting Officer
Guardant Health announced two key leadership appointments effective November 2, 2026. Kevin R. Sayer, the former CEO and current Executive Chairman of Dexcom,...
Guardant Health Inc Q3 2026 Earnings Preview: What Analysts Expect on November 05, 2026
Analysts expect Guardant Health to report Q3 2026 revenue of approximately $350.72 million, representing 32% year-over-year growth, alongside a consensus EPS...
Perceptive Advisors reduces Guardant Health stake by 86%
Perceptive Advisors, a major life-sciences investment firm, significantly cut its position in Guardant Health (GH) by 86.2%, an estimated $38.81 million trade....